According to Amylyx Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.22. In 2022 the company made an earnings per share (EPS) of -$3.43 a decrease over its 2021 EPS that were of -$1.73.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.22 | -64.43% |
2022 | -$3.43 | 98.78% |
2021 | -$1.73 |